A Multi-Center Prospective Non-Interventional Study of Real-World Effectiveness of Etrasimod in Patients with Ulcerative Colitis (ENDEAVOUR-UC)
Brief description of study
The purpose of this research study is to observe the effectiveness of Etrasimod (Velsipity®) in adults with moderately to severely active ulcerative colitis (UC).
The study consists of 52-weeks of follow-up from etrasimod initiation and an additional 28-day safety follow-up period.
Clinical Study Identifier: s24-00435
ClinicalTrials.gov Identifier: NCT06398626
Principal Investigator:
Jordan E Axelrad.
Other Investigators:
Elie S Al Kazzi,
Shannon Chang,
Adam Faye,
Simon J Hong,
Ariela Holmer,
David P Hudesman,
Bradley M. Morganstern.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.